Results 351 to 360 of about 2,747,170 (398)
Some of the next articles are maybe not open access.

Viral Vector Vaccines

VacciTUTOR, 2021
Viral vector vaccines use harmless, non-replicating or replicating viruses to deliver genetic material for production of vaccine antigens into host cell cytoplasm.
V. Oriol Mathieu   +3 more
semanticscholar   +1 more source

Viral vector targeting

Current Opinion in Biotechnology, 1999
The field of viral vector targeting is advancing rapidly. Recent advances include the successful use of bifunctional crosslinkers to target adenoviral and retroviral vectors, elucidation of the crystal structures of an adenoviral and a retroviral receptor-binding domain, and definition of strategies for inserting short targeting peptides and larger ...
Stephen J. Russell, Kah Whye Peng
openaire   +3 more sources

Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays

AAPS Journal, 2020
Viral vector–based gene therapies (GTx) have received significant attention in the recent years and the number of ongoing GTx clinical trials is increasing. A platform of choice for many of these studies is adeno-associated virus (AAV). All humans may be
B. Gorovits   +6 more
semanticscholar   +1 more source

Viral Vectors for Gene Therapy

Pharmacology & Therapeutics, 1998
Viruses have evolved to become highly efficient at nucleic acid delivery to specific cell types while avoiding immunosurveillance by an infected host. These properties make viruses attractive gene-delivery vehicles, or vectors, for gene therapy. Several types of viruses, including retrovirus, adenovirus, adeno-associated virus (AAV), and herpes simplex
Steven C. Ghivizzani, Paul D. Robbins
openaire   +6 more sources

Introduction to Viral Vectors

2011
Viral vector is the most effective means of gene transfer to modify specific cell type or tissue and can be manipulated to express therapeutic genes. Several virus types are currently being investigated for use to deliver genes to cells to provide either transient or permanent transgene expression.
Claire Daigre   +2 more
openaire   +3 more sources

Polycistronic Viral Vectors

Current Gene Therapy, 2002
Traditionally, vectors for gene transfer/therapy experiments were mono- or bicistronic. In the latter case, vectors express the gene of interest coupled with a marker gene. An increasing demand for more complex polycistronic vectors has arisen in recent years to obtain complex gene transfer/therapy effects.
openaire   +2 more sources

Gene Therapy with Viral Vectors

Annual Review of Pharmacology and Toxicology, 2003
A key factor in the success of gene therapy is the development of gene delivery systems that are capable of efficient gene transfer in a broad variety of tissues, without causing any pathogenic effect. Currently, viral vectors based on many different viruses have been developed, and their performance and pathogenicity has been evaluated in animal ...
Inder M. Verma, Neeltje A. Kootstra
openaire   +3 more sources

Viral Vectors in Gene Therapy

Annual Review of Microbiology, 1995
The use of DNA as a drug is both appealing and simple in concept. Indeed in many instances the feasibility of such an approach has been established using model systems. In practical terms, however, the delivery of DNA to human tissues presents a wide variety of problems that differ with each potential therapeutic application. In this review, the design,
openaire   +3 more sources

Viral Vectors for Gene Transfer

Current Protocols in Mouse Biology, 2018
AbstractViral vectors are a promising tool for effective delivery of genetic material into cells. They take advantage of the natural ability of a virus to deliver a genetic payload into cells while being genetically modified such that their ability to replicate is crippled or removed. Here, an updated overview of routinely used viral vectors, including
Yong Hong Chen   +3 more
openaire   +3 more sources

Viral Vectors for Cancer Immunotherapy

Frontiers in Bioscience, 2006
Over the last decade, immunotherapy approaches for the treatment of cancer have been investigated with renewed vigour, perhaps catalyzed by the clinical successes seen with monoclonal antibody and cytokine based therapies. The identification of tumor-associated antigens (TAAs) in multiple cancer types has enabled the development of targeted ...
Richard Harrop, Miles W. Carroll
openaire   +2 more sources

Home - About - Disclaimer - Privacy